[Autologous versus homologous transfusion in cervico-fascial oncologic and ENT surgery].
The objective was to evaluate the interest of the normovolemic hemodilution (NVH) in cervico-facial oncologic and ENT surgery. It was a prospective, randomised and simple blind study having included A(n = 17) having benefitted before induction of a blood withdrawal of 6-8 ml.kg-1, substituted by an intravenous drip of colloid. B group (n = 21). The transfusional objective having been to assure for the two groups, during operative and in postoperative periods, a rate of Hb > or = 10 g.dl-1 and a rate of Ht > or = 30%. The two groups were comparable for the demographic and anesthetic characteristics, and the blood losses during operative period. A variation significantly more important between before and postoperative hemoglobin has been objectified in the group A. The infectious morbidity was significantly more elevated in the group A (23.5% versus 4%). The cost was distinctly more elevated in the hemodiluted group. The NVH doesn't seem to be an indication of choice in the cervico-facial and ENT oncologic surgery.
Boussofara
M
M
Service de chirurgie cervico-faciale et ORL-Institut Salah Azaïz.
Dammak
R
R
Touazine
N
N
Zehani
S
S
Kaddour
C
C
Abdallah
M B
MB
Ladgham
A
A
D000368:Aged; D001804:Blood Transfusion, Autologous; D004423:Ear / Q000601:surgery; D005260:Female; D006258:Head and Neck Neoplasms / Q000601:surgery*; D017048:Health Care Costs; D006438:Hemodilution / Q000379:methods*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009296:Nasal Cavity / Q000601:surgery; D010614:Pharynx / Q000601:surgery; D011183:Postoperative Complications; D011446:Prospective Studies; D016037:Single-Blind Method; D013514:Surgical Procedures, Operative / Q000379:methods